XSHG
603077
Market cap2.53bUSD
Jul 10, Last price
2.16CNY
1D
0.47%
1Q
-26.78%
Jan 2017
-7.19%
IPO
78.76%
Name
Sichuan Hebang Biotechnology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Chengdu, China, Sichuan Hebang Biotechnology Corporation Limited, which originated in 2002, operates as a multifaceted enterprise. The company's core activities revolve around the development and distribution of products spanning agricultural, chemical, and advanced materials sectors. Its agricultural portfolio features biological pesticides, veterinary biological pharmaceuticals, and methionine. Within the chemical division, key offerings include sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. Additionally, the firm is a producer of various glass types, such as standard, smart, specialized, and low-emissivity coated glass, alongside photovoltaic packaging and module components. Another significant business line involves the supply of oil and natural gas. The company rebranded to its present name in April 2021, having previously been known as SichuanHebang Biotechnology Co.,Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||